Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Finished Goods: 2019-2020

Historic Finished Goods for CureVac N.V (CVAC) over the last 2 years, with Dec 2020 value amounting to $883,487.

  • CureVac N.V's Finished Goods was N/A to $24.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $24.9 million, marking a year-over-year change of. This contributed to the annual value of $883,487 for FY2020, which is 3890.86% up from last year.
  • According to the latest figures from FY2020, CureVac N.V's Finished Goods is $883,487, which was up 3,890.86% from $22,138 recorded in FY2019.
  • CureVac N.V's 5-year Finished Goods high stood at $883,487 for FY2020, and its period low was $22,138 during FY2019.
  • For the 2-year period, CureVac N.V's Finished Goods averaged around $452,812, with its median value being $452,812 (2019).
  • Data for CureVac N.V's Finished Goods shows a peak YoY surged of 3,890.86% (in 2020) over the last 5 years.
  • CureVac N.V's Finished Goods (Yearly) stood at $22,138 in 2019, then surged by 3,890.86% to $883,487 in 2020.